157 related articles for article (PubMed ID: 29331565)
1. Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue.
Kumar D; Goand UK; Gupta S; Shankar K; Varshney S; Rajan S; Srivastava A; Gupta A; Vishwakarma AL; Srivastava AK; Gaikwad AN
Eur J Pharmacol; 2018 Mar; 822():32-42. PubMed ID: 29331565
[TBL] [Abstract][Full Text] [Related]
2. Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice.
Goand UK; Verma S; Gupta AP; Garg R; Dadge S; Gayen JR
Peptides; 2023 Jan; 159():170902. PubMed ID: 36375661
[TBL] [Abstract][Full Text] [Related]
3. Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice.
Shankar K; Kumar D; Gupta S; Varshney S; Rajan S; Srivastava A; Gupta A; Gupta AP; Vishwakarma AL; Gayen JR; Gaikwad AN
Eur J Pharmacol; 2019 Jul; 854():354-364. PubMed ID: 30822393
[TBL] [Abstract][Full Text] [Related]
4. Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.
Sarkar S; Kumari D; Gupta SK; Sharma V; Mukhi S; Kamboj P; Sasibhushan V; Rai RK; Jatavallabhula SL; Mahajan D; Kumar Y; Kumar A; Dikshit M
Biomed Pharmacother; 2021 Dec; 144():112357. PubMed ID: 34794234
[TBL] [Abstract][Full Text] [Related]
5.
Osinski V; Bauknight DK; Dasa SSK; Harms MJ; Kroon T; Marshall MA; Garmey JC; Nguyen AT; Hartman J; Upadhye A; Srikakulapu P; Zhou A; O'Mahony G; Klibanov AL; Kelly KA; Boucher J; McNamara CA
Theranostics; 2020; 10(2):585-601. PubMed ID: 31903139
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.
Kamau F; Strijdom H; Mwangi P; Blackhurst D; Imperial E; Salie R
Vascul Pharmacol; 2019 Oct; 121():106577. PubMed ID: 31284000
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
[TBL] [Abstract][Full Text] [Related]
8. Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: Implications of nitric oxide.
Kumar D; Shankar K; Patel S; Gupta A; Varshney S; Gupta S; Rajan S; Srivastava A; Vishwakarma AL; Gaikwad AN
Mol Cell Endocrinol; 2018 Dec; 477():15-28. PubMed ID: 29753026
[TBL] [Abstract][Full Text] [Related]
9. Temporal immmunometabolic profiling of adipose tissue in HFD-induced obesity: manifestations of mast cells in fibrosis and senescence.
Kumar D; Pandya SK; Varshney S; Shankar K; Rajan S; Srivastava A; Gupta A; Gupta S; Vishwakarma AL; Misra A; Gaikwad AN
Int J Obes (Lond); 2019 Jun; 43(6):1281-1294. PubMed ID: 30301967
[TBL] [Abstract][Full Text] [Related]
10. The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.
Kumar DP; Caffrey R; Marioneaux J; Santhekadur PK; Bhat M; Alonso C; Koduru SV; Philip B; Jain MR; Giri SR; Bedossa P; Sanyal AJ
Sci Rep; 2020 Jun; 10(1):9330. PubMed ID: 32518275
[TBL] [Abstract][Full Text] [Related]
11. Cotadutide effect in liver and adipose tissue in obese mice.
Marcondes-de-Castro IA; Oliveira TF; Spezani R; Marinho TS; Cardoso LEM; Aguila MB; Mandarim-de-Lacerda CA
J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36753306
[TBL] [Abstract][Full Text] [Related]
12. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
[TBL] [Abstract][Full Text] [Related]
13. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
Makled MN; El-Kashef DH
Life Sci; 2020 Jul; 253():117729. PubMed ID: 32348836
[TBL] [Abstract][Full Text] [Related]
14. Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
Jain MR; Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Ranvir R; Kadam S; Patel H; Swain P; Roy SS; Das N; Karmakar E; Wahli W; Patel PR
Liver Int; 2018 Jun; 38(6):1084-1094. PubMed ID: 29164820
[TBL] [Abstract][Full Text] [Related]
15. Immuno-metabolic effect of pancreastatin inhibitor PSTi8 in diet induced obese mice: In vitro and in vivo findings.
Goand UK; Verma S; Patel I; Tasneem S; Garg R; Gayen JR
Life Sci; 2023 Mar; 316():121415. PubMed ID: 36690247
[TBL] [Abstract][Full Text] [Related]
16. Saroglitazar, a novel dual PPAR-α/γ agonist, reverses high fat-low protein diet-induced metabolic and cognitive aberrations in C57BL/6J male mice.
Dharavath RN; Arora S; Kondepudi KK; Bishnoi M; Chopra K
Life Sci; 2021 Apr; 271():119191. PubMed ID: 33571514
[TBL] [Abstract][Full Text] [Related]
17. Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation.
Varol C; Zvibel I; Spektor L; Mantelmacher FD; Vugman M; Thurm T; Khatib M; Elmaliah E; Halpern Z; Fishman S
J Immunol; 2014 Oct; 193(8):4002-9. PubMed ID: 25217161
[TBL] [Abstract][Full Text] [Related]
18. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
[TBL] [Abstract][Full Text] [Related]
19. Effect of acetylsalicylic acid on inflamed adipose tissue. Insulin resistance and hepatic steatosis in a mouse model of diet-induced obesity.
Sardi C; Martini E; Mello T; Camelliti S; Sfondrini L; Marcucci F; Kallikourdis M; Sommariva M; Rumio C
Life Sci; 2021 Jan; 264():118618. PubMed ID: 33141040
[TBL] [Abstract][Full Text] [Related]
20. Treatment with TUG891, a free fatty acid receptor 4 agonist, restores adipose tissue metabolic dysfunction following chronic sleep fragmentation in mice.
Gozal D; Qiao Z; Almendros I; Zheng J; Khalyfa A; Shimpukade B; Ulven T
Int J Obes (Lond); 2016 Jul; 40(7):1143-9. PubMed ID: 26980479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
